By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck Serono 

9, chemin des Mines
Case postale 54
Geneva    CH-1211  Switzerland
Phone: 41-22-414-3000 Fax: 41-22-731-2179



Company News
Merck Serono, Intrexon Corporation Ink $941M Pact, As Race for CAR-T Edge Continues 3/30/2015 10:03:41 AM
Intrexon Corporation And Merck Serono Announce Agreement For The Development And Commercialization Of CAR-T Therapy 3/30/2015 6:59:57 AM
Illumina (ILMN) Announces Strategic Collaboration With Merck Serono To Expand Companion Diagnostics For Oncology 3/10/2015 8:26:44 AM
Opexa Therapeutics (OPXA) Amends Agreement With Merck Serono And Receives Additional $3 Million Payment To Support Ongoing Development Of Tcelna For Multiple Sclerosis 3/9/2015 11:21:37 AM
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs 10/7/2014 6:01:16 AM
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014 5:54:01 AM
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014 6:38:13 AM
Merck Serono Breaks Ground On $105 Million Plant; Will Be The Company's Second Largest Manufacturing Facility Worldwide 8/28/2014 6:02:33 AM
Kadimastem To Collaborate With Merck Serono To Advance Combined Efforts In Neurodegenerative Disease Area 8/4/2014 11:11:36 AM
MorphoSys AG And Merck Serono Enter Strategic Immuno-Oncology Collaboration 6/12/2014 7:45:10 AM